Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 2013

View Archived Issues

A comparative analysis of the structural-antifungal activity of polyene antibiotics

TRK-390 as a novel and highly selective phosphate binder

Results presented for olaparib in EGFR NSCLC and BRCA-mutated ovarian cancer

LC-510201, a new S1P1/S1P5 receptor agonist for multiple sclerosis

AnGes' phase I/II study of HGF gene therapy in primary lymphedema begins in Japan

First-in-human data for the human monoclonal antibody KRN-23

Presentations describe preclinical data on hepatitis B treatment candidate bentysrepinine

HSV-2 vaccine protective in animal challenge model

Novel myostatin inhibitors patented

Vitae Pharmaceuticals presents new liver X receptor-beta agonists

Novel metabotropic glutamate mGlu2 receptor PAMs disclosed by Bristol-Myers Squibb

Dual orexin receptor antagonists discovered at Rottapharm

ConfirmMDx prostate cancer test meets primary endpoints in clinical validation study

Joslin Diabetes Center partners with Pfizer and Lilly

Researchers use DNA nanotechnology to develop super-high-resolution molecular imaging

Poxel reports data for imeglimin from human hyperglycemic clamp trial

FDA accepts IND application for LGD-6972 in type 2 diabetes

Ampio Pharmaceuticals reports results from independent panel review of Optina trial

GSK adds development candidate to its collaboration with Isis

Kitasato Institute and Tella to collaborate on dendritic cell vaccine study

Effimune and Janssen Biotech sign option and license agreement for FR-104

Immutep and Eddingpharm sign agreement for ImmuFact IMP-321 in China

Chugai seeks approval of alectinib hydrochloride in Japan

Eleison initiates phase III study of glufosfamide for second-line treatment of pancreatic cancer

Phase II study of Novavax's respiratory syncytial virus vaccine begins

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...